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BACKGROUND 
METHODS 
INTERVENTION 
CONCLUSION 
Results indicate that similar home-based RSTIs are safe, acceptable to survivors, and 
feasible to implement by cancer center staff. 
Further research with larger samples and possible monitoring of interruptions in total 
sedentary time may be needed to establish efficacy and effect sizes for the 
intervention. 
A larger dose or addition of behavior-activating components (use of daily activity 
trackers, text messages, or coaching) may be necessary to realize clinically- meaningful 
changes in sedentarism, daily activity, metabolism and behavior change. These 
preliminary results suggest provision of educational material/one-time feedback is 
likely insufficient to meet PA guidelines & reduce sedentary time. 
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M e t a b o l i c  p a r a m e t e r s  p r e -  a n d  p o s t  i n t e r v e n t i o n 
Mean ± SD. HDL- High density lipoprotein, LDL- Low density lipoprotein, IGI- Insulinogenic index; DI- Disposition 
Index. *p<0.05 
• Phase 1 proof-of-concept/feasibility trial 
• One Group Pre/Post-test Design 
ELIGIBILITY CRITERIA 
Designed to select a sample of breast cancer survivors most likely to benefit from a 
home-based intervention designed to reduce sedentary behavior. 
Inclusion Criteria: 
 Stage I-III breast cancer survivors age 20-80 who have completed 
primary treatment greater than 6 months but less than 5 years. 
Patients may be on adjuvant hormonal therapy. 
 BMI >25 
 Less than 150 min/week moderate to vigorous exercise 
 No gain or loss of >10% body weight over prior 6 months 
Exclusion Criteria: 
• Known diabetes 
• Known coronary artery disease 
• Pregnancy 
Table 3. Metabolic Outcomes 
RESULTS 
Table 2. Sedentary & Activity Outcomes 
Table 1. Participant Demographics (Total N=16) 
Figure 1. Study Flow (PA=Physical Activity, SB=Sedentary Behavior) 
Figure 2. ActivPAL Accelerometer 
Figure 3. Personalized Feedback & Suggestions for Environmental 
Modifications to Reduce Sedentarism (selected pages) 
TIPS TO 
  GET UP &  GET M OVIN G   
M at erials Developed for “ Act ivit y Study for Breast Cancer 
Survivors” Sponsored by The Rays of Hope Cent er for Breast 
Cancer Research 
& Baystat e M edical Cent er, in partnership wit h t he 
University of M assachuset t s Am herst 
A Simple Guid e You Can Use t o: 
· A ssess How  &  W hen You Ar e M ost  A ct 
ive 
· Set  Realist ic Goals 
· Be W ell &  M ake Posit ive Chang es 
n=13 Pre-intervention Post-intervention (%) change P-value 
Hormones and metabolites 
Fasting glucose (mg/dl) 126.1 ± 44.1 127.4 ± 34.2 +1.0 0.87 
1h glucose (mg/dl) 180.2 ± 95.8 188.5 ± 82.4 +4.6 0.51 
Fasting insulin (uU/ml) 15.3 ± 6.2 17.5 ± 9.0 +14.4 0.25 
1h insulin (uU/ml) 121.6 ± 61.8 123.1 ± 58.3 + 1.2 0.84 
Leptin (ng/ml) 55.5 ± 31.6 44.6 ± 26.0 - 19.6         0.01* 
C-reactive protein (ng/ml) 237.1 ± 257.4 225.3 ± 259.5 - 5.0 0.68 
Triglyceride (mg/dl) 107.2 ± 58.8 112.8 ± 52.8 + 5.2 0.49 
Total Cholesterol (mg/dl) 189.9 ± 22.2 195.6 ± 18.4 + 3.0 0.32 
HDL Cholesterol (mg/dl) 52.9 ± 14.6 58.5 ± 20.6 + 10.6 0.07 
LDL Cholesterol (mg/dl) 114.9 ± 26.6 114.6 ± 26.9 - 0.2 0.95 
Metrics of glycemic control 
HOMA-IR 2.2 ± 1.1 2.4 ± 1.3 + 9.0 0.34 
HOMA-%B 86.9 ± 22.7 89.1 ± 24.1 + 2.1 0.75 
IGI(0-60) 0.40 ± 0.97 0.57 ± 0.73 + 42.5 0.34 
DI(HOMA-IR x IGI) 1.26 ± 2.69 1.56 ± 2.19 +23.8 0.51 
INTERPRETING YOUR WEEKLY ACTIVITY PATTERNS 
IF YOU ARE ENROLLED IN THE STUDY, YOU WILL RECEIVE FEEDBACK ABOUT YOUR 
ACTIVITY PATTERNS. A DEVICE CALLED THE ‘ACTIVPAL’ WILL BE USED TO COLLECT 
THIS INFO. 
This is what the activPal wearable monitor looks like: 
This is how the activPAL presents information about your activity during the 
day. It detects when you are sitting or lying down (yellow bars), standing (green 
bars) or walking & running (red bars).  This is recorded for each hour of the day. 
The feedback from the device looks like the EXAMPLE below: 
In this examp le , from around 1240pm to 
1250pm,  this person got up & walked 
around . 
In this examp le , this person spent all of the time between 1pm -2pm sitt ing down at their 
desk doing work. If this person was you  – you could think about what you m ight have 
been doing from 1pm -2pm that day. Are there ways you could b reak up that hour of 
sitt ing? 
GET UP & GET MOVING AT WORK 
• Create a Standing W orkstation 
• Stand to Answer the Phone & Answer Email 
• Do Walking Meetings 
• Hand Deliver Messages to Coworkers (Instead of Email) 
• Use a Restroom on a Different Floor 
• Take the Stairs! 
• Eat Your Lunch Outside or Away from your Desk 
• Use Copier or Printer Down the Hall/Away from your Desk 
• Stand & Stretch Each Time You Switch Tasks 
• Set Activity Reminder Alarms on Your Phone or Computer 
• Form a Walking Group & Walk at Lunch 
• Schedule Meetings in Rooms Away from Your Workstation 
• Park Father Away & Walk to W ork 
Physical activity (PA) promotion and sedentary behavior reduction among 
cancer survivors is a national priority1   and the number of PA-based behavioral 
interventions has expanded considerably in recent years.2 
There have been relatively few trials focused on reduction of sedentary 
time among cancer survivors due in part to past limitations related to 
precise quantitative measurement of sedentary behaviors.3 
 
 
Many PA interventions rely on clinic-based coaching which is both time- 
intensive and unrealistic for many clinics.4 
The purpose of this study was to investigate the feasibility and effects of a 
home based 6 week reduced sedentary time intervention (RSTI) in breast 
cancer survivors who had completed primary treatment. 
ClinicalTrials.gov NCT02969291 
Variable Name Average (SD) T-Test 
(* = p < .05) 
Total daily steps Baseline:            6190.40 (2086.25) 
Post Intervention: 6326.30 (2788.41) 
0.76 
Total energy expenditure/day 
(MET/hr.) 
Baseline:            33.05 (0.92) 
Post:            33.11 (1.16) 
0.74 
% of hourly time spent in uninterrupted 
sedentary behavior (8am-8pm) 
Baseline:            20% (13%) 
Post Intervention: 22% (11%) 
0.63 
Participants 
No. Completed study 13 
Race Black 3 
                              White 13 
Median Age (range) 61.3  (49-73) 
Median Time since diagnosis 34.4 months (11-55) 
(range) 
Prior Therapy Radiation 13 
                              Chemotherapy 11 
                              Hormonal 12 
